[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fYBuvDQVTSLNFUF7PVnPFg9rpYD4x4xqOZQRfWwgiZho":8,"$fmAYT0IDXt1L0cOIYJTSjkSFcZ7zEGmBOlU9OvDoaKqo":55,"$fu6DRML0hOMYENF3CcMrJEyW1Drg_Xl1mS7FRMV0-jVY":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},67801,867568,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//Qwz6GyCWTi4XHRajDQhvP0c86fSiOy65.png","李文旭","温州老年病医院","肿瘤科","主治医师",317,0,"肺癌 IIIA期非角化鳞癌用药安全宝典","","https://ystcdn.venuertc.com/venue/AI/ed94daaf-6263-425d-ab2e-9a250accf09e.jpg","\u003Cdiv class=\"lungcancer-material-container\">\n  \u003Ch2 id=\"material_title\" class=\"lungcancer-material-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">肺癌 IIIA期非角化鳞癌用药安全宝典\u003C/h2>\n  \u003Cdiv class=\"lungcancer-material-lead\">\n    \u003Cspan class=\"lungcancer-material-lead-emoji\">💊\u003C/span>\n    \u003Cspan>\n      说起来，治疗非角化鳞癌时，会用到多种药物组合，比如含铂化疗药、免疫治疗药。每种药品都有自己的使用规则和注意事项。如果你正关心这类药物的安全用法，这篇文章帮你抓住7个不可忽视的用药细节，提升治疗体验，把风险降到最低。\n    \u003C/span>\n  \u003C/div>\n\n  \u003C!-- 01 药品类别与主要成分简介 -->\n  \u003Csection class=\"lungcancer-material-block lungcancer-material-bg1\">\n    \u003Ch2 class=\"lungcancer-material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 药品主要类型与成分特点\u003C/h2>\n    \u003Cdiv class=\"lungcancer-material-section-body\">\n      \u003Cp>\n        IIIA期非角化鳞癌治疗时，主要使用以下药物类别：\n      \u003C/p>\n      \u003Cul class=\"lungcancer-material-list\">\n        \u003Cli>\n          \u003Cb>含铂类化疗药：\u003C/b>如顺铂、卡铂。典型剂型为注射液。顺铂为无色液体，卡铂为透明液体，两者均通过静脉滴注给药。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>紫杉类药物：\u003C/b>如紫杉醇，常配合含铂药物联合使用。紫杉醇为注射液，需专业护士操作灌输。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>免疫检查点抑制剂：\u003C/b>如程序性死亡受体-1（PD-1）或其配体（PD-L1）单抗，包括纳武利尤单抗、帕博利珠单抗等。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp class=\"lungcancer-material-tips lungcancer-material-bg-tip\">\n        \u003Cspan class=\"lungcancer-material-emoji\">🧪\u003C/span>正确做法：用药前充分了解药品成分和剂型。若需知晓具体配方或药品全名，请向医生或药师咨询，不要擅自更换药物。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 02 药理作用机制简述 -->\n  \u003Csection class=\"lungcancer-material-block lungcancer-material-bg2\">\n    \u003Ch2 class=\"lungcancer-material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 药物如何发挥作用？\u003C/h2>\n    \u003Cdiv class=\"lungcancer-material-section-body\">\n      \u003Cul class=\"lungcancer-material-list\">\n        \u003Cli>\n          含铂化疗药主要作用在细胞DNA上，干扰细胞分裂，使异常细胞难以继续生长。\n        \u003C/li>\n        \u003Cli>\n          紫杉类药物可阻碍微管功能，从而终止细胞分裂过程。\n        \u003C/li>\n        \u003Cli>\n          免疫检查点抑制剂能够激活身体自身免疫系统，让免疫细胞更有效地清除异常细胞。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        每种药物的效果，都直接与其机制相关，但实际疗效会因个体差异、基因表达（如PD-L1 TPS值）等因素而不同。\n      \u003C/p>\n      \u003Cp class=\"lungcancer-material-tips lungcancer-material-bg-tip\">\n        \u003Cspan class=\"lungcancer-material-emoji\">🌱\u003C/span>实际用药应根据医生建议综合使用，不要自行增减药品。\n      \u003C/p>\n      \u003Cp class=\"lungcancer-material-note\">参考文献：Paz-Ares, L., et al. (2020). \"Immunotherapy for NSCLC: Current Status and Future.\" Nature Reviews Clinical Oncology, 17(2), 75-89.\u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 03 用药时间与服用方法 -->\n  \u003Csection class=\"lungcancer-material-block lungcancer-material-bg3\">\n    \u003Ch2 class=\"lungcancer-material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 用药时间与正确服用方式\u003C/h2>\n    \u003Cdiv class=\"lungcancer-material-section-body\">\n      \u003Cul class=\"lungcancer-material-list\">\n        \u003Cli>\n          含铂药和紫杉醇一般按周期静脉滴注，具体间隔（如每三周一次）由医生根据方案确定。\n        \u003C/li>\n        \u003Cli>\n          免疫抑制剂一般也是静脉注射，但周期可为2、3或4周，剂量需严格按照医嘱。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        正确做法：所有药品都必须在专业医院环境下由医护人员操作，绝不可以自行购买或注射。服药期间需动态监控身体状况，每一次用药前后均要确认自身无过敏史或严重基础疾病史。\n      \u003C/p>\n      \u003Cp class=\"lungcancer-material-tips lungcancer-material-bg-tip\">\n        \u003Cspan class=\"lungcancer-material-emoji\">🔄\u003C/span>静脉注射药物期间，保持充足的水分摄入，有助于药物代谢和减少毒性积聚。\n      \u003C/p>\n      \u003Cp class=\"lungcancer-material-note\">临床案例：有位患者完成2周期含铂方案化疗，未见明显不良反应，通过规律滴注获得良好耐受性。\u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 04 剂型特性与服药技巧 -->\n  \u003Csection class=\"lungcancer-material-block lungcancer-material-bg4\">\n    \u003Ch2 class=\"lungcancer-material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 剂型特性与具体用药技巧\u003C/h2>\n    \u003Cdiv class=\"lungcancer-material-section-body\">\n      \u003Cul class=\"lungcancer-material-list\">\n        \u003Cli>\n          注射液药物不宜剧烈摇晃，注射前要充分复核外观和有效期，药液混浊或沉淀即需更换。\n        \u003C/li>\n        \u003Cli>\n          免疫抑制剂现多为即用制剂，输液前需确认药瓶的批号和有效期。\n        \u003C/li>\n        \u003Cli>\n          部分药物使用时对针头或管路有特殊材质要求（如紫杉醇不得用PVC输液管），由护士专门负责。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        建议：如果发现药品有漏液、标签不清，务必拒绝使用并通知药师。切勿在家自行分装或保存注射液。\n      \u003C/p>\n      \u003Cp class=\"lungcancer-material-tips lungcancer-material-bg-tip\">\n        \u003Cspan class=\"lungcancer-material-emoji\">💡\u003C/span>服药当天建议适量进食、保持良好休息状态，有助于减少输液过程中的不适。\n      \u003C/p>\n      \u003Cp class=\"lungcancer-material-note\">参考文献：Ettinger, D. S., et al. (2022). \"NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2022.\" Journal of the National Comprehensive Cancer Network, 20(8), 785-795.\u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 05 药物相互作用与用药禁忌 -->\n  \u003Csection class=\"lungcancer-material-block lungcancer-material-bg5\">\n    \u003Ch2 class=\"lungcancer-material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 药物相互作用与用药禁忌\u003Cspan class=\"lungcancer-material-emoji\">⚠️\u003C/span>\u003C/h2>\n    \u003Cdiv class=\"lungcancer-material-section-body\">\n      \u003Cul class=\"lungcancer-material-list\">\n        \u003Cli>\n          含铂化疗药与抗菌药物（如氨基糖苷类）共同使用时，肾损伤风险增大，不建议同时用药。\n        \u003C/li>\n        \u003Cli>\n          紫杉类药物与免疫抑制剂叠加可能增加周期性骨髓抑制作用，用法需严格分期。\n        \u003C/li>\n        \u003Cli>\n          部分降压药、抗凝药对化疗过程有干扰，如需共同使用必须提示用药医生。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        特殊禁忌：已知对铂类药物、紫杉醇等有严重过敏史者禁用。孕期妇女禁用大部分化疗药物。严重肾功能不全、骨髓抑制患者用药需要个体化调整。\n      \u003C/p>\n      \u003Cp class=\"lungcancer-material-tips lungcancer-material-bg-tip\">\n        \u003Cspan class=\"lungcancer-material-emoji\">⏰\u003C/span>如需增减其他药品，特别提醒：务必提前告知医师所有在用药物，包括保健品。\n      \u003C/p>\n      \u003Cp class=\"lungcancer-material-note\">参考文献：Rosell, R., et al. (2018). \"Platinum-based Chemotherapy in NSCLC: Current Status.\" Chest, 153(5), 1107-1117.\u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 06 药物不良反应及处理方法 -->\n  \u003Csection class=\"lungcancer-material-block lungcancer-material-bg6\">\n    \u003Ch2 class=\"lungcancer-material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 药物不良反应与应对措施\u003C/h2>\n    \u003Cdiv class=\"lungcancer-material-section-body\">\n      \u003Cul class=\"lungcancer-material-list\">\n        \u003Cli>\n          含铂药可引起恶心、呕吐、肾损伤等，临床数据显示，顺铂引起胃肠道反应概率约60%。（参考：说明书数据）\n        \u003C/li>\n        \u003Cli>\n          紫杉类药物常见不良反应为脱发、白细胞减少。\n        \u003C/li>\n        \u003Cli>\n          免疫治疗药物有可能导致皮疹、肝功能异常，但发生率低于20%。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        处理方法：出现上述不适，应及时就医，由医师动态调整化疗周期或用药强度。切勿自行减量或停药。部分症状可通过预防性服用止吐药、抗过敏药辅助缓解，但需在医师指导下进行。\n      \u003C/p>\n      \u003Cp class=\"lungcancer-material-tips lungcancer-material-bg-tip\">\n        \u003Cspan class=\"lungcancer-material-emoji\">🛡\u003C/span>有位患者在联用药物后，无显著不良反应，但仍需密切监控白细胞、肝肾指标，防止迟发反应。\n      \u003C/p>\n      \u003Cp class=\"lungcancer-material-note\">参考文献：Antonia, S. J., et al. (2017). \"Safety and Efficacy of Immune Checkpoint Inhibitors in NSCLC.\" The Lancet Oncology, 18(8), 1086-1096.\u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 07 药品储存要求与有效期管理 -->\n  \u003Csection class=\"lungcancer-material-block lungcancer-material-bg7\">\n    \u003Ch2 class=\"lungcancer-material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 药品储存及过期药管理\u003C/h2>\n    \u003Cdiv class=\"lungcancer-material-section-body\">\n      \u003Cul class=\"lungcancer-material-list\">\n        \u003Cli>\n          注射类化疗药需冷藏保存（2-8℃），避免阳光直射，防止药品变质。\n        \u003C/li>\n        \u003Cli>\n          免疫抑制剂储存要求视具体制剂，部分室温保存，开封后限时用完。\n        \u003C/li>\n        \u003Cli>\n          一旦药品超过有效期或液体出现异色、沉淀，应严格报废，不得自行处理。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        正确做法：药品必须由医院药房统一管理，患者不得将药品带回家中储存。对家庭中偶尔剩余的药品，建议送回医院药房集中处理，切勿丢弃。\n      \u003C/p>\n      \u003Cp class=\"lungcancer-material-tips lungcancer-material-bg-tip\">\n        \u003Cspan class=\"lungcancer-material-emoji\">📦\u003C/span>所有化疗相关药品非专业人员不得接触或保存，防止药品误用或泄漏。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 08 特殊人群用药及剂量调整 -->\n  \u003Csection class=\"lungcancer-material-block lungcancer-material-bg8\">\n    \u003Ch2 class=\"lungcancer-material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 特殊人群的用药注意点\u003C/h2>\n    \u003Cdiv class=\"lungcancer-material-section-body\">\n      \u003Cul class=\"lungcancer-material-list\">\n        \u003Cli>\n          老年患者通常需根据体重和肾功能适当下调剂量，以减少毒性累积。\n        \u003C/li>\n        \u003Cli>\n          儿童极少用此类药物，剂量和疗程需专科团队评估。\n        \u003C/li>\n        \u003Cli>\n          孕妇和哺乳期妇女一般禁用多数化疗和免疫药物，避免对胎儿和婴儿造成影响。\n        \u003C/li>\n        \u003Cli>\n          肝肾功能不全者需先进行功能评估，必要时单独调整剂型与给药强度。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        推荐做法：用药前主动与医生沟通自身健康状况，特别是老年、肝肾损伤、妊娠哺乳期群体，不可随意服用其他药物。\n      \u003C/p>\n      \u003Cp class=\"lungcancer-material-tips lungcancer-material-bg-tip\">\n        \u003Cspan class=\"lungcancer-material-emoji\">👨‍👩‍👧‍👦\u003C/span>一位60岁患者在肾功能监测合格后顺利完成标准剂量化疗，疗程顺利，无毒性累积现象。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 09 漏服、过量用药及紧急处理 -->\n  \u003Csection class=\"lungcancer-material-block lungcancer-material-bg9\">\n    \u003Ch2 class=\"lungcancer-material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 漏服与过量用药处理方法\u003C/h2>\n    \u003Cdiv class=\"lungcancer-material-section-body\">\n      \u003Cul class=\"lungcancer-material-list\">\n        \u003Cli>\n          漏服化疗药品应及时向主治医生报告，根据医生评估调整下个周期，不可私自补药。\n        \u003C/li>\n        \u003Cli>\n          过量用药可能导致严重骨髓抑制、器官损伤，应第一时间前往医院处理，等待对症支持和解毒措施。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        正确做法：所有化疗和免疫药物都应由医护人员操作，患者本人不可自行服用或注射。如果一次漏服或不慎使用过量，切记不要慌张，按医嘱处理即可。\n      \u003C/p>\n      \u003Cp class=\"lungcancer-material-tips lungcancer-material-bg-tip\">\n        \u003Cspan class=\"lungcancer-material-emoji\">🚨\u003C/span>如出现异常反应，包括持续不适、明显体力下降，及时就医是保障安全的唯一选择。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 10 用药后随访与健康管理 -->\n  \u003Csection class=\"lungcancer-material-block lungcancer-material-bg10\">\n    \u003Ch2 class=\"lungcancer-material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 用药后的健康管理与随访细节\u003C/h2>\n    \u003Cdiv class=\"lungcancer-material-section-body\">\n      \u003Cul class=\"lungcancer-material-list\">\n        \u003Cli>\n          定期随访：合理用药后，建议每周期（2-4周）检查血常规、肝肾功能和药物相关指标。\n        \u003C/li>\n        \u003Cli>\n          饮食调整：用药期间适量高蛋白饮食，忌辛辣刺激。\n        \u003C/li>\n        \u003Cli>\n          心理支持：化疗期间可以适度寻求心理疏导，帮助缓解情绪波动，减少用药压力。\n        \u003C/li>\n        \u003Cli>\n          家庭支持：用药期间家人参与关怀，有利于发现用药相关的早期问题。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        最关键细节：每次用药后、随访期间，都要主动记录身体变化，发现任何异常及时反馈，协助医生调整方案。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 总结 -->\n  \u003Csection class=\"lungcancer-material-summary lungcancer-material-bg-summary\">\n    \u003Ch2 class=\"lungcancer-material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">最后提醒\u003C/h2>\n    \u003Cdiv>\n      \u003Cp>\n        本文梳理了非角化鳞癌常用药品的关键用药细节，覆盖药品选择、用法、相互作用、不良反应、特殊人群、储存及随访等环节。治疗过程中，安全用药是基础，规范操作是关键。务必记住：所有静脉药物只能由专业人员操作，遇到任何用药相关问题，第一时间联系医生。\n      \u003C/p>\n      \u003Cp>\n        最后，建议每位读者都随时关注自身用药安全，把握每个细节，就是治愈路上的一大步。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 文献引用 -->\n  \u003Csection class=\"lungcancer-material-ref lungcancer-material-bg-ref\">\n    \u003Ch2 class=\"lungcancer-material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">文献引用（APA格式）\u003C/h2>\n    \u003Col>\n      \u003Cli>\n        Paz-Ares, L., et al. (2020). Immunotherapy for NSCLC: Current Status and Future. \u003Ci>Nature Reviews Clinical Oncology, 17\u003C/i>(2), 75-89.\n      \u003C/li>\n      \u003Cli>\n        Ettinger, D. S., et al. (2022). NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2022. \u003Ci>Journal of the National Comprehensive Cancer Network, 20\u003C/i>(8), 785-795.\n      \u003C/li>\n      \u003Cli>\n        Rosell, R., et al. (2018). Platinum-based Chemotherapy in NSCLC: Current Status. \u003Ci>Chest, 153\u003C/i>(5), 1107-1117.\n      \u003C/li>\n      \u003Cli>\n        Antonia, S. J., et al. (2017). Safety and Efficacy of Immune Checkpoint Inhibitors in NSCLC. \u003Ci>The Lancet Oncology, 18\u003C/i>(8), 1086-1096.\n      \u003C/li>\n    \u003C/ol>\n  \u003C/section>\n\u003C/div>\n\u003Cstyle>\n.lungcancer-material-container {\n  font-family: \"Helvetica Neue\", Arial, \"PingFang SC\", \"Microsoft YaHei\", sans-serif;\n  background: #f6fafd;\n  color: #23232b;\n  max-width: 920px;\n  margin: 0 auto;\n  border-radius: 18px;\n  padding: 32px 38px;\n  box-shadow: 0 2px 12px 0 rgba(20,80,100,0.08);\n}\n.lungcancer-material-title {\n  text-align: center;\n  font-size: 38px;\n  color: #20547b;\n  margin-bottom: 24px;\n  letter-spacing: 1px;\n}\n.lungcancer-material-lead {\n  background: linear-gradient(90deg,#e5f8ff 30%,#f7fafc);\n  font-size: 18px;\n  color: #305172;\n  border-radius: 8px;\n  padding: 18px 16px 14px 16px;\n  margin-bottom: 18px;\n  display: flex;\n  align-items: center;\n  font-weight: 500;\n}\n.lungcancer-material-lead-emoji {\n  font-size: 28px;\n  margin-right: 14px;\n}\n.lungcancer-material-block {\n  padding: 20px 18px 22px 18px;\n  border-radius: 11px;\n  margin-bottom: 24px;\n  box-shadow: 0 1px 10px 0 rgba(190,210,215,0.09);\n}\n.lungcancer-material-h2 {\n  font-size: 26px;\n  font-weight: bold;\n  color: #3076a4;\n  padding-bottom: 10px;\n  margin-top: 0;\n  margin-bottom: 11px;\n  letter-spacing: 0.5px;\n}\n.lungcancer-material-bg1 {\n  background: linear-gradient(110deg,#e6f6f3 45%,#fdfeff 100%);\n}\n.lungcancer-material-bg2 {\n  background: linear-gradient(105deg,#ecf5fc 55%,#f7fafc 100%);\n}\n.lungcancer-material-bg3 {\n  background: linear-gradient(125deg,#f2fcfa 33%,#eef1f6 94%);\n}\n.lungcancer-material-bg4 {\n  background: linear-gradient(120deg,#f9f5ff 61%,#f8fbf9 100%);\n}\n.lungcancer-material-bg5 {\n  background: linear-gradient(125deg, #f2f5ff 38%, #eef8fc 100%);\n}\n.lungcancer-material-bg6 {\n  background: linear-gradient(120deg,#edf8f5 63%,#fcfcfe 100%);\n}\n.lungcancer-material-bg7 {\n  background: linear-gradient(120deg,#feffe6 59%,#f8faf9 100%);\n}\n.lungcancer-material-bg8 {\n  background: linear-gradient(130deg,#f6f9ff 30%,#fff 100%);\n}\n.lungcancer-material-bg9 {\n  background: linear-gradient(110deg, #f8f4fa 39%, #f7fafc 93%);\n}\n.lungcancer-material-bg10 {\n  background: linear-gradient(120deg,#f6fffb 60%,#f8fbfa 100%);\n}\n.lungcancer-material-section-body {\n  font-size: 19px;\n  color: #344d5b;\n  line-height: 1.9;\n}\n.lungcancer-material-list {\n  padding-left: 22px;\n  margin-bottom: 14px;\n}\n.lungcancer-material-list li {\n  margin-bottom: 9px;\n  font-size: 18px;\n  line-height: 1.7;\n}\n.lungcancer-material-note {\n  font-size: 16px;\n  color: #6897ae;\n  padding: 6px 0 0 0;\n  margin-bottom: 0;\n}\n.lungcancer-material-tips {\n  font-size: 17px;\n  color: #075c3e;\n  padding: 9px 12px;\n  margin-top: 15px;\n  margin-bottom: 6px;\n  border-radius: 6px;\n  font-weight: 500;\n  letter-spacing: 0.4px;\n  display: flex;\n  align-items: center;\n}\n.lungcancer-material-bg-tip {\n  background: linear-gradient(90deg,#eafcee 70%,#fafdfe 100%);\n  border-left: 5px solid #29c289;\n  box-sizing: border-box;\n}\n.lungcancer-material-emoji {\n  font-size: 22px;\n  margin-right: 7px;\n}\n.lungcancer-material-summary {\n  background: linear-gradient(100deg,#f3f5fa 80%,#eaf3ff 100%);\n  padding: 22px 20px;\n  border-radius: 14px;\n  margin-bottom: 22px;\n  color: #3e6078;\n  font-size: 20px;\n  line-height: 2;\n  font-weight: 500;\n}\n.lungcancer-material-ref {\n  background: linear-gradient(90deg,#e9f2fb 98%,#fafbfc 100%);\n  padding: 22px 20px;\n  border-radius: 10px;\n  color: #325588;\n  font-size: 17px;\n  line-height: 2;\n}\n.lungcancer-material-bg-summary {\n  border-left: 7px solid #5b88c6;\n}\n.lungcancer-material-bg-ref {\n  border-left: 7px solid #4ca0e2;\n}\n@media (max-width: 600px) {\n  .lungcancer-material-container {\n    padding: 15px 4px;\n    font-size: 16px;\n    box-shadow: none;\n  }\n  .lungcancer-material-title {\n    font-size: 23px;\n    margin-bottom: 17px;\n  }\n  .lungcancer-material-h2 {\n    font-size: 18px;\n    padding-bottom: 6px;\n    margin-bottom: 6px;\n  }\n  .lungcancer-material-section-body, .lungcancer-material-summary {\n    font-size: 16px;\n    line-height: 2.1;\n  }\n}\n\u003C/style>\n","\u003Cdiv class=\"lungcancer-material-container\">\n  \u003Ch2 id=\"material_title\" class=\"lungcancer-material-tit",436,"2025-10-13 17:20:00","肺癌, 非角化鳞癌, 用药安全, 药物不良反应, 化疗药物, 免疫治疗药物, 药物相互作用, 管理措施","了解肺癌III期非角化鳞癌的治疗药物、安全使用细节、药物相互作用与不良反应，确保治疗的专业性与安全性，提高疗效。","2025-11-04 10:30:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]